Sirion's Zirgan approved for herpetic keratitis in the US
This article was originally published in Scrip
Executive Summary
The US FDA has approved Sirion Therapeutics's Zirgan (ganciclovir) ophthalmic gel 0.15% for the treatment of acute herpetic keratitis, nearly 10 years after the antiviral was approved for the same indication in Europe. The private company plans to start selling the drug in January 2010.